Industry | 2016.04.15
VxP Pharma announces launch of VxP Biologics, Inc. focusing on the Contract Development & cGMP Manufacturing of Biologics for Clinical Trials at its US-FDA Audited Sites
VxP Biologics is now offering process development and manufacturing of biologics, including recombinant DNA engineering, cell line development, protein sciences (purification and crystallography), in-vivo pharmacology, toxicology, as well as cGMP antibody generation. All VxP Biologics facilities are US-FDA audited, and are currently serving the global pharmaceutical and biotech industry.
(PRWeb April 14, 2016)
Read the full story at http://www.prweb.com/releases/2016/04/prweb13336345.htm
For more information, please visit
http://www.prweb.com/releases/2016/04/prweb13336345.htm
